RSS

generics

A surge of international partnerships and biosimilars is helping drive South Korea’s pharmaceutical market, new findings show. Read more

News

Patients may need to wait an extra five or 10 years to access generic medicines, according to the latest CPhI annual report. Read more

News

Sanofi Genzyme — specialty care global business unit of French pharma company Sanofi — has launched its multiple sclerosis (MS) drug in India, however, according to GlobalData, it should be cautious of fierce generic competition… Read more

News

According to CPhI Korea, the Korean pharma market is experiencing significant growth in finished drug products, which is being attributed to an expanding domestic generics market. Read more

Analysis

Sanofi and Advent International have finalised negotiations for the acquisition of Zentiva — Sanofi’s European generics business — with both companies signing a Share Purchase Agreement worth €1.9 billion. Read more

News

Manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), Cambrex, has announced that it will expand research and development capabilities at its Milan site. Read more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

Commissioner of the US Food and Drug Administration (FDA), Dr Scott Gottlieb, has released a statement highlighting new efforts to raise awareness of situations where drug makers may be ‘pursuing gaming tactics to delay generic competition’ Read more

News

Event organisers, UBM, have reported that next month’s CPhI Japan 2018 will play host to an increased number of international generic active pharmaceutical ingredient (API) companies and suppliers. Read more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

Accord Healthcare, a generic pharmaceutical company, has opened a new facility in Fawdon, Newcastle, expanding its portfolio to four sites situated within the UK. Read more

News

The new not-for-profit generic pharmaceutical company, to be created by five hospital organisations, is unlikely to benefit the contract manufacturing organisation (CMO) industry, according to data and analytics company, GlobalData. Read more

News

Five organisations that represent more than 450 hospitals in the US are working together to develop a not-for-profit generic drug company to make more essential medications more widely available and less expensive. Read more

News

A recent report from CPhI Japan has forecast that this year, 2018, will be a transformative year for Japanese pharma as the market is expected to see growth in generics, biosimilars and internationalisation. Read more

Analysis

The first generics pharmaceutical manufacturer in Spain, Norman Laboratories, has selected TraceLink’s serialisation solutions to meet the forthcoming EU Falsified Medicines Directive (FMD) requirements. Read more

News

Russian biotechnology company, BIOCAD, has revealed plans to enter the European market with oncological and autoimmune medicines. Read more

News

The findings from the final section (part iii) of the CPhI Annual Report have been announced by event organisers UBM. Read more

Analysis

During this year’s CPhI Worldwide congress in Frankfurt, the India Brand Equity Foundation and the Pharmaceuticals Export Promotion Council provided an update on India’s generics market, confirming it accounts for 98% of the marketplace Read more

Analysis